Humanigen Inc (HGENQ)

[cowtown jay]

I've been curious about how management would time the upcoming events. Specifically, I wondered if management would begin to roll-out our immediate course change before or after the bankruptcy was concluded. Now we know.

Some years ago, I was disappointed that a number of prospective investors were denied purchases of shares because we were over-subscribed. I had hoped that management would accommodate them, which they did not do. But that was the right business decision at that time, just as concluding the bankruptcy before announcing new developments is the right business decision at this time.

I'm truly not concerned in the least bit. If short sellers were students of what this management team has done by capitalizing on the design of their share structure, they would have saved themselves the pending circumstance of being forced to buy-in their borrowed shares by submitting a bid to the bankruptcy judge. Now, however, I will be happy to provide shares at $200 for them to cover their short positions.

If Big Pharma deduced that Humanigen has created partnerships with Novavax and Gracell, and that we have a pathway to regulatory approval, even if initially overseas, they, too, would have submitted bids for the company. But Gilead's Daniel O'Day, and others, couldn't quite envision that, and will lose substantial market share in the near term, as a consequence.